跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Blazen
Approved
STANDARD
Blazen
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
460ed739b2f02c5d
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
460ed739b2f02c5d
Drug Approval Philippines Name
Blazen
Product Name
Blazen
Registration Number
DRP-14872-01
Brand Name
Blazen
Generic Name
Bilastine
Dosage Form
Tablet
Dosage Strength
20 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ajanta Pharma Philippines Inc.
Issuance Date
27 September 2024
Expiry Date
26 January 2029
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
460ed739b2f02c5d
Type
Standard
Back to Philippines FDA Approvals